Simvastatin Completed Phase 3 Trials for Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02070133Efficacy of Simvastatin for the Treatment of COPD
NCT01944176The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients